The Food and Drug Administration is advising consumers not to purchase or use Special Edition Platinum 10K, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.
Similar Posts
AlzClipp / UniUni – 711274 – 07/29/2025
Unapproved New Drugs/MisbrandedDrug Safety Communications
FDA Drug Safety Communications connect consumers and health care professionals to important drug safety information. The webpage contains the most recent Drug Safety Communications from FDA as well as links for Early Communications, Follow-Up Early Communications, Information for Healthcare ProfessiMelcare Biomedical Pty Ltd – 717968 – 10/09/2025
Nonprescription/OTC.”Howard I. Schwartz, M.D. Hollywood, FL. EIR issued 11/19/2020
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 11/19/2020
Short Title (70 char) Howard I. Schwartz, M.D. Hollywood, FL. EIR issued 11/19/2020
FEI Number 1000525885
Firm Name Howard I. Schwartz, M.D.
Record Type EIR
State FL
Establishment Type Clinical InvestFDA approves new treatment for acromegaly, a rare endocrine disorder
The U.S. Food and Drug Administration (FDA) approved Palsonify (paltusotine) tablets to treat adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option.Questions and Answers on the iPLEDGE REMS
Questions and Answers on the iPLEDGE REMS